Investment Summary |
|
|---|---|
| Date | 2021-04-12 |
| Target | Trucking Innovation |
| Sector | Transportation |
| Investor(s) | Advantage Capital Partners |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Agnostic |
Advantage Capital Partners is a private equity firm focused on providing growth capital to a variety of companies. The Firm's geographic coverage includes Alabama, Colorado, Florida, Hawaii, Louisiana, Mississippi, Missouri, New York, Texas, Wisconsin and Washington DC. Advantage looks to initially commit $0.5 to $2 million per investment and can provide mezzanine debt in addition to equity capital. Areas of interest include communications, information technology, life science, and energy. Advantage Capital was formed in 1992 and is headquartered in New Orleans, Louisiana.
| DEAL STATS | # |
|---|---|
| Overall | 311 of 329 |
| Sector: Transportation M&A | 4 of 4 |
| Type: Growth Capital M&A Deals | 129 of 137 |
| State: Louisiana M&A | 18 of 21 |
| Country: United States M&A | 307 of 325 |
| Year: 2021 M&A | 16 of 24 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-04-01 |
ITS
Reno, Nevada, United States ITS is a global supplier of highly engineered cleaning materials supporting the semiconductor industry. ITS products are used for advanced probe cards at parametric test & wafer sort operations (PCC), test socket applications during package test (TCC) and chuck cleaning at front- and backend tools (CCW). ITS was founded in 1999 and is based in Reno, Nevada. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-04-16 |
Recursion Pharmaceuticals
Salt Lake City, Utah, United States Recursion Pharmaceuticals is a drug discovery company. Recursion uses a novel drug screening platform to efficiently repurpose and reposition drugs to treat rare genetic diseases. Recursion’s novel drug screening platform combines experimental biology and bioinformatics in a massively parallel system to quickly and efficiently identify treatments for multiple rare genetic diseases. Recursion Pharmaceuticals was founded in 2013 and is based in Salt Lake City, Utah. |
Sell | - |
